Get started
INTUITIVE SURGICAL INC COM USD0.001INTUITIVE SURGICAL INC COM USD0.001INTUITIVE SURGICAL INC COM USD0.001

INTUITIVE SURGICAL INC COM USD0.001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0R29 chart


Full chart

0R29 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪190.51 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
86.4
Basic EPS (TTM)
6.3 USD
Net income (FY)
‪1.80 B‬ USD
Revenue (FY)
‪7.12 B‬ USD
Shares float
‪353.99 M‬
Beta (1Y)
1.10

Employees


Employees (FY)
‪13.68 K‬
Change (1Y)
‪+1.56 K‬ +12.84%
Revenue / Employee (1Y)
‪520.92 K‬ USD
Net income / Employee (1Y)
‪131.47 K‬ USD

About Intuitive Surgical, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Gary S. Guthart
Website
intuitive.com
Headquarters
Sunnyvale
Founded
1995
FIGI
BBG00JRQS2C3
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0R29 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0R29 is 523.5 USD — it has decreased by −0.36% in the past 24 hours. Watch INTUITIVE SURGICAL INC COM USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange INTUITIVE SURGICAL INC COM USD0.001 stocks are traded under the ticker 0R29.
0R29 stock has risen by 2.78% compared to the previous week, the month change is a −1.97% fall, over the last year INTUITIVE SURGICAL INC COM USD0.001 has showed a 54.87% increase.
We've gathered analysts' opinions on INTUITIVE SURGICAL INC COM USD0.001 future price: according to them, 0R29 price has a max estimate of 650.00 USD and a min estimate of 475.00 USD. Watch 0R29 chart and read a more detailed INTUITIVE SURGICAL INC COM USD0.001 stock forecast: see what analysts think of INTUITIVE SURGICAL INC COM USD0.001 and suggest that you do with its stocks.
0R29 reached its all-time high on Dec 9, 2024 with the price of 558.2 USD, and its all-time low was 125.7 USD and was reached on Mar 17, 2020. View more price dynamics on 0R29 chart.
See other stocks reaching their highest and lowest prices.
0R29 stock is 2.44% volatile and has beta coefficient of 1.10. Track INTUITIVE SURGICAL INC COM USD0.001 stock price on the chart and check out the list of the most volatile stocks — is INTUITIVE SURGICAL INC COM USD0.001 there?
Today INTUITIVE SURGICAL INC COM USD0.001 has the market capitalization of ‪190.51 B‬, it has increased by 2.00% over the last week.
Yes, you can track INTUITIVE SURGICAL INC COM USD0.001 financials in yearly and quarterly reports right on TradingView.
INTUITIVE SURGICAL INC COM USD0.001 is going to release the next earnings report on Jan 23, 2025. Keep track of upcoming events with our Earnings Calendar.
0R29 earnings for the last quarter are 1.84 USD per share, whereas the estimation was 1.64 USD resulting in a 12.05% surprise. The estimated earnings for the next quarter are 1.75 USD per share. See more details about INTUITIVE SURGICAL INC COM USD0.001 earnings.
INTUITIVE SURGICAL INC COM USD0.001 revenue for the last quarter amounts to ‪2.04 B‬ USD, despite the estimated figure of ‪2.01 B‬ USD. In the next quarter, revenue is expected to reach ‪2.20 B‬ USD.
0R29 net income for the last quarter is ‪565.10 M‬ USD, while the quarter before that showed ‪526.90 M‬ USD of net income which accounts for 7.25% change. Track more INTUITIVE SURGICAL INC COM USD0.001 financial stats to get the full picture.
No, 0R29 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has ‪13.68 K‬ employees. See our rating of the largest employees — is INTUITIVE SURGICAL INC COM USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INTUITIVE SURGICAL INC COM USD0.001 EBITDA is ‪2.52 B‬ USD, and current EBITDA margin is 30.91%. See more stats in INTUITIVE SURGICAL INC COM USD0.001 financial statements.
Like other stocks, 0R29 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INTUITIVE SURGICAL INC COM USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INTUITIVE SURGICAL INC COM USD0.001 technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INTUITIVE SURGICAL INC COM USD0.001 stock shows the buy signal. See more of INTUITIVE SURGICAL INC COM USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.